U.S. Food and Drug Administration Oncology Drugs Update

You are subscribed to Oncology Drugs for U.S. Food and Drug Administration. This information has recently been updated, and is now available. FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial cancer Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA